US Stock MarketDetailed Quotes

Sangamo Therapeutics (SGMO)

Watchlist
  • 0.1350
  • -0.0005-0.37%
15min DelayClose May 15 15:59 ET
55.93MMarket Cap-0.31P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sangamo Therapeutics (SGMO) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-44.79%-97.21M
-628.23%-24.4M
-342.35%-28.5M
32.46%-18.16M
46.27%-26.15M
70.14%-67.14M
93.37%-3.35M
124.86%11.76M
55.72%-26.88M
26.60%-48.66M
Net income from continuing operations
-25.52%-122.93M
-59.94%-37.42M
-427.31%-34.93M
44.68%-19.99M
37.67%-30.6M
62.01%-97.94M
61.20%-23.4M
110.25%10.67M
68.45%-36.13M
-332.29%-49.09M
Operating gains losses
----
----
----
----
----
---1.03M
----
----
----
----
Depreciation and amortization
-18.79%7.6M
-11.80%1.88M
-10.77%1.9M
-26.27%1.9M
-23.83%1.92M
-57.82%9.36M
-29.05%2.14M
-71.33%2.13M
-58.38%2.57M
-54.74%2.53M
Deferred tax
----
----
----
----
--15K
--0
87.14%-18K
-90.11%18K
--0
--0
Other non cash items
-43.86%32K
-104.92%-3K
--0
--45K
---10K
-94.91%57K
--61K
--99K
----
----
Change In working capital
-193.72%-4.22M
-127.57%-4.23M
153.82%2.41M
-191.64%-2.33M
99.13%-77K
102.75%4.51M
1,858.75%15.34M
-67.30%-4.47M
176.19%2.54M
94.40%-8.9M
-Change in receivables
-83.74%155K
-98.40%152K
98.55%-151K
-100.20%-6K
113.81%160K
197.64%953K
357.68%9.53M
-576.89%-10.42M
-27.01%3M
67.60%-1.16M
-Change in prepaid assets
-81.07%830K
384.76%4.06M
-154.40%-1.84M
-15.57%1.24M
-373.49%-2.63M
-57.25%4.38M
-127.94%-1.42M
967.61%3.38M
317.93%1.47M
-84.54%962K
-Change in payables and accrued expense
169.39%5.85M
74.31%-934K
4,829.93%6.48M
-216.88%-3.32M
148.35%3.63M
-18.66%-8.43M
-257.97%-3.64M
97.83%-137K
-61.58%2.84M
28.62%-7.5M
-Change in other current liabilities
24.60%-4.4M
52.77%-845K
-5.00%-1.32M
36.89%-1M
-2.58%-1.23M
-15.36%-5.83M
-24.93%-1.79M
-2.27%-1.26M
-31.73%-1.59M
-0.84%-1.2M
-Change in other working capital
-149.57%-6.66M
----
----
----
----
108.33%13.43M
952.26%12.66M
29.58%3.97M
----
----
Cash from discontinued investing activities
Operating cash flow
-44.79%-97.21M
-628.23%-24.4M
-342.35%-28.5M
32.46%-18.16M
46.27%-26.15M
70.14%-67.14M
93.37%-3.35M
124.86%11.76M
55.72%-26.88M
26.60%-48.66M
Investing cash flow
Cash flow from continuing investing activities
-100.27%-102K
-101.06%-14K
-127.47%-64K
-118.90%-24K
0
-75.56%37.52M
-96.49%1.32M
-99.38%233K
-99.70%127K
0.31%35.84M
Net PPE purchase and sale
61.80%-102K
90.79%-14K
44.35%-64K
----
----
98.74%-267K
94.31%-152K
95.81%-115K
--0
--0
Net investment purchase and sale
--0
--0
--0
--0
--0
-79.48%35.84M
--0
--0
--0
-21.96%35.84M
Net other investing changes
----
----
----
----
----
--1.95M
--1.48M
--348K
----
----
Cash from discontinued investing activities
Investing cash flow
-100.27%-102K
-101.06%-14K
-127.47%-64K
-118.90%-24K
--0
-75.56%37.52M
-96.49%1.32M
-99.38%233K
-99.70%127K
0.31%35.84M
Financing cash flow
Cash flow from continuing financing activities
149.32%70.75M
111.66%14.8M
9,560.10%19.2M
5,468.48%28.61M
-63.23%8.13M
94.52%28.38M
4,086.23%6.99M
-103.00%-203K
-108.18%-533K
176.46%22.12M
Net common stock issuance
154.11%73.67M
112.00%14.98M
--19.47M
4,909.17%28.86M
-54.00%10.36M
91.92%28.99M
--7.07M
--0
-110.01%-600K
147.22%22.52M
Proceeds from stock option exercised by employees
18.62%344K
13.89%164K
--1K
----
----
-68.98%290K
-33.33%144K
--0
----
----
Net other financing activities
-260.95%-3.26M
-58.64%-349K
-31.53%-267K
-431.65%-420K
-453.98%-2.23M
37.78%-904K
-348.98%-220K
-100.99%-203K
59.28%-79K
63.75%-402K
Cash from discontinued financing activities
Financing cash flow
149.32%70.75M
111.66%14.8M
9,560.10%19.2M
5,468.48%28.61M
-63.23%8.13M
94.52%28.38M
4,086.23%6.99M
-103.00%-203K
-108.18%-533K
176.46%22.12M
Net cash flow
Beginning cash position
-7.04%43.42M
-24.99%30.53M
43.40%39.84M
-51.78%26.68M
-7.04%43.42M
-54.19%46.7M
-29.84%40.7M
-59.34%27.79M
-30.61%55.33M
-54.19%46.7M
Current changes in cash
-2,045.48%-26.56M
-293.80%-9.62M
-179.38%-9.36M
138.23%10.43M
-293.73%-18.02M
97.82%-1.24M
139.20%4.96M
220.71%11.79M
-132.77%-27.29M
141.20%9.3M
Effect of exchange rate changes
299.76%4.09M
101.78%40K
-96.27%42K
1,163.04%2.73M
290.60%1.28M
-238.10%-2.05M
-266.08%-2.25M
304.73%1.13M
-182.11%-257K
-282.56%-670K
End cash Position
-51.75%20.95M
-51.75%20.95M
-24.99%30.53M
43.40%39.84M
-51.78%26.68M
-7.04%43.42M
-7.04%43.42M
-29.84%40.7M
-59.34%27.79M
-30.61%55.33M
Free cash flow
-44.36%-97.31M
-597.03%-24.42M
-345.29%-28.56M
32.37%-18.18M
46.27%-26.15M
72.60%-67.41M
93.42%-3.5M
123.27%11.64M
59.42%-26.88M
36.39%-48.66M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -44.79%-97.21M-628.23%-24.4M-342.35%-28.5M32.46%-18.16M46.27%-26.15M70.14%-67.14M93.37%-3.35M124.86%11.76M55.72%-26.88M26.60%-48.66M
Net income from continuing operations -25.52%-122.93M-59.94%-37.42M-427.31%-34.93M44.68%-19.99M37.67%-30.6M62.01%-97.94M61.20%-23.4M110.25%10.67M68.45%-36.13M-332.29%-49.09M
Operating gains losses -----------------------1.03M----------------
Depreciation and amortization -18.79%7.6M-11.80%1.88M-10.77%1.9M-26.27%1.9M-23.83%1.92M-57.82%9.36M-29.05%2.14M-71.33%2.13M-58.38%2.57M-54.74%2.53M
Deferred tax ------------------15K--087.14%-18K-90.11%18K--0--0
Other non cash items -43.86%32K-104.92%-3K--0--45K---10K-94.91%57K--61K--99K--------
Change In working capital -193.72%-4.22M-127.57%-4.23M153.82%2.41M-191.64%-2.33M99.13%-77K102.75%4.51M1,858.75%15.34M-67.30%-4.47M176.19%2.54M94.40%-8.9M
-Change in receivables -83.74%155K-98.40%152K98.55%-151K-100.20%-6K113.81%160K197.64%953K357.68%9.53M-576.89%-10.42M-27.01%3M67.60%-1.16M
-Change in prepaid assets -81.07%830K384.76%4.06M-154.40%-1.84M-15.57%1.24M-373.49%-2.63M-57.25%4.38M-127.94%-1.42M967.61%3.38M317.93%1.47M-84.54%962K
-Change in payables and accrued expense 169.39%5.85M74.31%-934K4,829.93%6.48M-216.88%-3.32M148.35%3.63M-18.66%-8.43M-257.97%-3.64M97.83%-137K-61.58%2.84M28.62%-7.5M
-Change in other current liabilities 24.60%-4.4M52.77%-845K-5.00%-1.32M36.89%-1M-2.58%-1.23M-15.36%-5.83M-24.93%-1.79M-2.27%-1.26M-31.73%-1.59M-0.84%-1.2M
-Change in other working capital -149.57%-6.66M----------------108.33%13.43M952.26%12.66M29.58%3.97M--------
Cash from discontinued investing activities
Operating cash flow -44.79%-97.21M-628.23%-24.4M-342.35%-28.5M32.46%-18.16M46.27%-26.15M70.14%-67.14M93.37%-3.35M124.86%11.76M55.72%-26.88M26.60%-48.66M
Investing cash flow
Cash flow from continuing investing activities -100.27%-102K-101.06%-14K-127.47%-64K-118.90%-24K0-75.56%37.52M-96.49%1.32M-99.38%233K-99.70%127K0.31%35.84M
Net PPE purchase and sale 61.80%-102K90.79%-14K44.35%-64K--------98.74%-267K94.31%-152K95.81%-115K--0--0
Net investment purchase and sale --0--0--0--0--0-79.48%35.84M--0--0--0-21.96%35.84M
Net other investing changes ----------------------1.95M--1.48M--348K--------
Cash from discontinued investing activities
Investing cash flow -100.27%-102K-101.06%-14K-127.47%-64K-118.90%-24K--0-75.56%37.52M-96.49%1.32M-99.38%233K-99.70%127K0.31%35.84M
Financing cash flow
Cash flow from continuing financing activities 149.32%70.75M111.66%14.8M9,560.10%19.2M5,468.48%28.61M-63.23%8.13M94.52%28.38M4,086.23%6.99M-103.00%-203K-108.18%-533K176.46%22.12M
Net common stock issuance 154.11%73.67M112.00%14.98M--19.47M4,909.17%28.86M-54.00%10.36M91.92%28.99M--7.07M--0-110.01%-600K147.22%22.52M
Proceeds from stock option exercised by employees 18.62%344K13.89%164K--1K---------68.98%290K-33.33%144K--0--------
Net other financing activities -260.95%-3.26M-58.64%-349K-31.53%-267K-431.65%-420K-453.98%-2.23M37.78%-904K-348.98%-220K-100.99%-203K59.28%-79K63.75%-402K
Cash from discontinued financing activities
Financing cash flow 149.32%70.75M111.66%14.8M9,560.10%19.2M5,468.48%28.61M-63.23%8.13M94.52%28.38M4,086.23%6.99M-103.00%-203K-108.18%-533K176.46%22.12M
Net cash flow
Beginning cash position -7.04%43.42M-24.99%30.53M43.40%39.84M-51.78%26.68M-7.04%43.42M-54.19%46.7M-29.84%40.7M-59.34%27.79M-30.61%55.33M-54.19%46.7M
Current changes in cash -2,045.48%-26.56M-293.80%-9.62M-179.38%-9.36M138.23%10.43M-293.73%-18.02M97.82%-1.24M139.20%4.96M220.71%11.79M-132.77%-27.29M141.20%9.3M
Effect of exchange rate changes 299.76%4.09M101.78%40K-96.27%42K1,163.04%2.73M290.60%1.28M-238.10%-2.05M-266.08%-2.25M304.73%1.13M-182.11%-257K-282.56%-670K
End cash Position -51.75%20.95M-51.75%20.95M-24.99%30.53M43.40%39.84M-51.78%26.68M-7.04%43.42M-7.04%43.42M-29.84%40.7M-59.34%27.79M-30.61%55.33M
Free cash flow -44.36%-97.31M-597.03%-24.42M-345.29%-28.56M32.37%-18.18M46.27%-26.15M72.60%-67.41M93.42%-3.5M123.27%11.64M59.42%-26.88M36.39%-48.66M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -